EFFICACY AND SAFETY OF DOUBLE VS. STANDARD DOSE RECOMBINANT HEPATITIS B VACCINE IN INFANTS BORN TO HBSAG-POSITIVE MOTHERS:AN INTERIM REPORT OF A MULTI-CENTER, RANDOMIZED AND CONTROLLED TRIAL

被引：0
|
作者：
Duan, Zhongping [1 ]
Zou, Huaibin [1 ]
Chen, Yu [1 ]
Zhang, Hua [2 ]
Li, Yujie [3 ]
Dai, Erhei [4 ]
Liu, Zhongsheng [5 ]
Pan, Calvin [6 ]
机构：
[1] Capital Med Univ, Artificial Liver Ctr, Beijing YouAn Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Dept Obstet & Gynecol, Beijing YouAn Hosp, Beijing, Peoples R China
[3] Taiyuan Infect Dis Hosp, Taiyuan, Peoples R China
[4] Shijiazhuang Fifth Hosp, Shijiazhuang, Peoples R China
[5] Tongliao Infect Dis Hosp, Tonglio, Peoples R China
[6] Mt Sinai Sch Med, Div Liver Dis, Flushing, NY USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：884A / 885A
页数：2
相关论文
共 35 条
  • [21] Study on efficacy and safety of Tong-luo Qu-tong plaster treatment for knee osteoarthritis: study protocol for a randomized, double-blind, parallel positive controlled, multi-center clinical trial
    Xu, Bao-ping
    Yao, Min
    Tian, Zi-rui
    Zhou, Long-yun
    Yang, Long
    Li, Zhen-jun
    Zhu, Sen
    Wang, Xiao-tao
    Lan, Jia-hui
    Wang, Yong-jun
    Cui, Xue-jun
    TRIALS, 2019, 20 (1)
  • [22] Study on efficacy and safety of Tong-luo Qu-tong plaster treatment for knee osteoarthritis: study protocol for a randomized, double-blind, parallel positive controlled, multi-center clinical trial
    Bao-ping Xu
    Min Yao
    Zi-rui Tian
    Long-yun Zhou
    Long Yang
    Zhen-jun Li
    Sen Zhu
    Xiao-tao Wang
    Jia-hui Lan
    Yong-jun Wang
    Xue-jun Cui
    Trials, 20
  • [23] Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China
    Xiaoke Li
    Ludan Zhang
    Mei Qiu
    Yi Huang
    Huanming Xiao
    Bingjiu Lu
    Yuyong Jiang
    Fuli Long
    Hui Lin
    Jinyu He
    Qikai Wu
    Mingxiang Zhang
    Li Wang
    Xiaoning Zhu
    Man Gong
    Xuehua Sun
    Jianguang Sun
    Fengxia Sun
    Wei Lu
    Weihua Xu
    Guang Chen
    Zhiguo Li
    Danan Gan
    Xianzhao Yang
    Hongbo Du
    Yong’an Ye
    Trials, 21
  • [24] Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Evaluate the Efficacy and Safety of HAD-B1 for Dose-Finding in EGFR Mutation Positive and Locally Advanced or Metastatic NSCLC Subjects Who Need Afatinib Therapy
    Ko, Eun-Ju
    Kwag, Eun-Bin
    Park, Ji Hye
    Park, So-Jung
    Son, Ji-Woong
    Yoon, Seong-Hun
    Shin, Seong-Hun
    Yoo, Hwa-Seung
    INTEGRATIVE CANCER THERAPIES, 2021, 20
  • [25] Efficacy and safety of MCO-010 optogenetic therapy for vision restoration in patients with severe vision loss due to retinitis pigmentosa: A phase 2b randomized, sham-controlled, multi-center, multi-dose, double-masked clinical trial (RESTORE)
    Boyer, David
    Bergstrom, Lance
    Emanuelli, Andres
    Gonzalez, Victor
    Wykoff, Charles
    Gupta, Sunil
    Liao, David
    Zak, Vitaliy
    Chavala, Sai
    Mohanty, Samar
    Bataybal, Subrata
    Piltz-Seymour, Jody
    Ayyagari, Ananta
    Koester, John
    Osborne, Aaron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [26] A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
    Kim, Hyung Joon
    Kim, Ju Hyun
    Yeon, Jong Eun
    Seo, Yeon Seok
    Jang, Jeong Won
    Cho, Yong Kyun
    Jang, Byoung Kuk
    Han, Byung Hoon
    Lee, Changhyeong
    Lee, Joon Hyeok
    Yoon, Jung-Hwan
    Kim, Kang Mo
    Kim, Moon Young
    Kim, Do Young
    Park, Neung Hwa
    Cho, Eun Young
    Lee, June Sung
    Lee, Jin-Woo
    Kim, In Hee
    Song, Byung-Cheol
    Lee, Byung-Seok
    Kwon, Oh Sang
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (11)
  • [27] Multi-center, randomized, double-blind, placebo-controlled, exploratory study to evaluate the efficacy and safety of HAD-B1 for dose-finding in EGFR positive and locally advanced or metastatic NSCLC subjects who need Afatinib therapy Study protocol clinical trial (SPIRIT Compliant)
    Park, So-Jung
    Kang, Hwi-Joong
    Jun, Hyung-Joon
    Shin, Seong-Hoon
    Yoo, Hwa-Seung
    MEDICINE, 2020, 99 (04)
  • [28] EFFICACY AND SAFETY OF ORAL TLR8 AGONIST GS-9688 IN VIRALLY-SUPPRESSED ADULT PATIENTS WITH CHRONIC HEPATITIS B: A PHASE 2, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED, MULTI-CENTER STUDY
    Gane, Edward J.
    Zhao, Yang
    Tan, Susanna
    Lau, Audrey H.
    Gaggar, Anuj
    Subramanian, Mani
    Kottilil, Shyam
    Tang, Lydia
    HEPATOLOGY, 2019, 70 : 435A - 436A
  • [29] Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
    Roozen, Geert V. T.
    Sukwa, Nsofwa
    Chirwa, Masuzyo
    White, Jessica A.
    Estrada, Marcus
    Maier, Nicole
    Turbyfill, Kevin R.
    Laird, Renee M.
    Suvarnapunya, Akamol E.
    Sayeh, Aicha
    D'Alessio, Flavia
    Marion, Candice
    Pattacini, Laura
    Hoogerwerf, Marie-Astrid
    Murugan, Rajagopal
    Terrinoni, Manuela
    Holmgren, Jan R.
    Sirima, Sodiomon B.
    Houard, Sophie
    Simuyandi, Michelo
    Roestenberg, Meta
    VACCINES, 2025, 13 (01)
  • [30] Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled Phase 2b Dry Eye Disease Clinical Trial to Evaluate Safety and Efficacy of Topical Ocular Reproxalap, a Novel RASP Inhibitor
    Sheppard, John D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
1234